The purpose of the study is to collect in vivo human image data to demonstrate neurological magnetic resonance imaging (MRI) of subjects using short pulse sequences.

This is a single-site; open-label, prospective research Study involving human subjects. There will be no comparative efficacy or safety analysis and therefore no randomization

Inclusion Criteria:

• Subject must be at least 18 years of age
• Subject must be willing and able to undergo verbal and written informed consent
• Subject must have a clinical indication for a head MRI with and without Gadolinium-based contrast agent administration

Exclusion Criteria:

• Subjects who have any of the conditions below at the time of the enrollment or scan session are excluded from this study. Further, should it be determined by study staff that an enrolled subject meets any of the conditions below during the course of the study, the subject will be removed from the study.

  • Any contraindication to an MRI scan per the policy of Spectrum Health
  • Any contraindication to administration of an MRI contrast agent per the policy of Spectrum Health
  • Off-label utilization of contrast agents administered for the subject's clinical exam

images collected